D-cycloserine facilitates extinction but does not eliminate renewal of the conditioned emotional response.

scientific article published in October 2006

D-cycloserine facilitates extinction but does not eliminate renewal of the conditioned emotional response. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1037/0735-7044.120.5.1159
P698PubMed publication ID17014266

P2093author name stringMark E Bouton
Amanda M Woods
P433issue5
P921main subjectcycloserineQ418508
P304page(s)1159-1162
P577publication date2006-10-01
P1433published inBehavioral NeuroscienceQ4880707
P1476titleD-cycloserine facilitates extinction but does not eliminate renewal of the conditioned emotional response.
P478volume120

Reverse relations

cites work (P2860)
Q47973852A return to the psychiatric dark ages with a two-system framework for fear.
Q57292216Acute and long-lasting effects of oxytocin in cortico-limbic circuits: consequences for fear recall and extinction
Q39427245Acute, but not chronic, exposure to d-cycloserine facilitates extinction and modulates spontaneous recovery of a conditioned taste aversion
Q37257029Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention.
Q43272463Alterations of excitatory transmission in the lateral amygdala during expression and extinction of fear memory
Q35551573An N-methyl-D-aspartate receptor agonist facilitates sleep-independent synaptic plasticity associated with working memory capacity enhancement
Q30375098An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials
Q27001253Behavioral and neurobiological mechanisms of extinction in Pavlovian and instrumental learning
Q30410131Can fear extinction be enhanced? A review of pharmacological and behavioral findings
Q30443020Cholinergic blockade frees fear extinction from its contextual dependency
Q35043180Cognitive enhancers for facilitating drug cue extinction: insights from animal models
Q37122960D-cycloserine accelerates the extinction of cocaine-induced conditioned place preference in C57bL/c mice
Q24626679D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning
Q28266461D-cycloserine effects on extinction of conditioned responses to drug-related cues
Q36794617D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.
Q37036822D-cycloserine facilitates context-specific fear extinction learning
Q46302123D-cycloserine facilitates extinction of conditioned alcohol-seeking behaviour in rats
Q34054882D-cycloserine reduces the context specificity of pavlovian extinction of cocaine cues through actions in the nucleus accumbens
Q50628293Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial.
Q40974359Effects of D-cycloserine on extinction and reconditioning of ethanol-seeking behavior in mice
Q35129785Effects of D-cycloserine on the extinction of appetitive operant learning
Q46934826Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD.
Q24615107Epigenetic mechanisms underlying extinction of memory and drug-seeking behavior
Q30394729Epigenetics and memory: causes, consequences and treatments for post-traumatic stress disorder and addiction
Q36050594Erasing fear memories with extinction training.
Q30478600Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction
Q42002480Fear and anxiety take a double hit from vagal nerve stimulation
Q30475516Fibroblast growth factor-2 enhances extinction and reduces renewal of conditioned fear
Q30503573Generalization of fear inhibition by disrupting hippocampal protein synthesis-dependent reconsolidation process
Q43992008GluA1 phosphorylation at serine 831 in the lateral amygdala is required for fear renewal
Q30477927Glutamate receptors in extinction and extinction-based therapies for psychiatric illness
Q92937988Hormonal, reproductive, and behavioural predictors of fear extinction recall in female rats
Q37077248Immediate extinction causes a less durable loss of performance than delayed extinction following either fear or appetitive conditioning
Q36302972Implications of learning theory for developing programs to decrease overeating
Q48859271Intraamygdala infusion of fibroblast growth factor 2 enhances extinction and reduces renewal and reinstatement in adult rats
Q50464991Ketamine accelerates fear extinction via mTORC1 signaling.
Q34277629Learning to forget: manipulating extinction and reconsolidation processes to treat addiction
Q33772516Low-dose systemic scopolamine disrupts context conditioning in rats
Q28396555Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders
Q30492380Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference
Q37863149Modulation of fear memory by retrieval and extinction: a clue for memory deconsolidation
Q24604822NMDA receptors and fear extinction: implications for cognitive behavioral therapy
Q26853333Neural and cellular mechanisms of fear and extinction memory formation
Q29616240Neural mechanisms of extinction learning and retrieval
Q34224871Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments.
Q64218012New Pharmacotherapeutic Approaches to Obsessive-Compulsive Disorder
Q30476965Nicotine and extinction of fear conditioning
Q38852116On the Road to Translation for PTSD Treatment: Theoretical and Practical Considerations of the Use of Human Models of Conditioned Fear for Drug Development
Q33740875Opposing effects of D-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior
Q34721646Pharmacological enhancement of drug cue extinction learning: translational challenges
Q30462825Pharmacological enhancement of fear reduction: preclinical models.
Q34661221Pharmacological enhancement of memory and executive functioning in laboratory animals.
Q33906803Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders--the case of yohimbine
Q27006437Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders
Q35970477Relapse processes after the extinction of instrumental learning: renewal, resurgence, and reacquisition
Q52609947Running from fear: Exercise modulation of fear extinction.
Q28541084SSCC TD: a serial and simultaneous configural-cue compound stimuli representation for temporal difference learning
Q30466738Seeking a spotless mind: extinction, deconsolidation, and erasure of fear memory
Q37110683Stress enhances the consolidation of extinction memory in a predictive learning task
Q33821292Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors
Q46972944Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction
Q37082575Targeting extinction and reconsolidation mechanisms to combat the impact of drug cues on addiction
Q28685095The Plasticity of Extinction: Contribution of the Prefrontal Cortex in Treating Addiction through Inhibitory Learning
Q46434328The facilitative effects of D-cycloserine on extinction of a cocaine-induced conditioned place preference can be long lasting and resistant to reinstatement
Q30371197Voluntary exercise during extinction of auditory fear conditioning reduces the relapse of fear associated with potentiated activity of striatal direct pathway neurons
Q34872584Why behavior change is difficult to sustain
Q35787895d-cycloserine reverses the detrimental effects of stress on learning in females and enhances retention in males

Search more.